Edition:
United Kingdom

Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)

CRBP.OQ on NASDAQ Stock Exchange Global Market

7.95USD
20 Sep 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.95
Open
--
Day's High
--
Day's Low
--
Volume
431
Avg. Vol
108,998
52-wk High
$9.85
52-wk Low
$4.53

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.85 -0.211
Mar '18 0.95 -0.207
FY 2017 Dec '17 0.00 -0.199
Sep '17 0.80 -0.139
Jun '17 0.35 -0.145
Mar '17 1.29 -0.161
FY 2016 Dec '16 0.38 -0.171
Sep '16 0.74 -0.122
Jun '16 0.40 -0.108
Mar '16 0.40 -0.077
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 1.12 1.90 0.00 0.17
Quarter Ending Dec-18 5 1.49 3.16 0.00 0.17
Year Ending Dec-18 5 4.41 6.25 1.80 0.70
Year Ending Dec-19 5 5.22 12.50 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 5 -0.22 -0.20 -0.25 -0.09
Quarter Ending Dec-18 5 -0.23 -0.19 -0.28 -0.09
Year Ending Dec-18 5 -0.86 -0.80 -0.95 -0.65
Year Ending Dec-19 5 -0.99 -0.85 -1.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 134.55 114.98 5.74
Price to Book (MRQ) 9.89 15.51 5.00
Price to Tangible Book (MRQ) 9.89 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 31.38 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -11.70 411.53 8.01
Sales (TTM) vs TTM 1 Yr. Ago 108.00 80.36 5.63
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.45 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -89.47 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 6.37 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.10 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.17
EBITD Margin (TTM) -996.89 -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -1,001.05 -759.72 4.32
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -1,002.11 -733.57 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -1,002.11 -734.94 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.39 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 110,485 23,228,954 860,374,110
Net Income/Employee (TTM) -1,107,175 3,144,136 101,207,069
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.08 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -82.39 -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -100.08 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -100.21 3.27 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % 194.80 -- --
EPS (TTM) % -72.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Corbus Pharmaceuticals Holdings Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.63 5.85 99 52
13 Week 15.62 9.99 99 66
26 Week 2.78 -5.03 99 80
52 Week -15.04 -27.99 79 50
YTD -12.43 -23.09 66 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 43.05%
# of Holders: 116
Total Shares Held: 24,629,438
3 Mo. Net Change: 485,395
# New Positions: 20
# Closed Positions: 17
# Increased Positions: 64
# Reduced Positions: 40
# Net Buyers: 24
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.